BJDX Bluejay Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BJDX

Price (delayed)

$0.55

Market cap

$1.48M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.08

Enterprise value

-$376,893

Highlights
Bluejay Diagnostics's debt has decreased by 28% YoY and by 9% from the previous quarter
BJDX's EPS is up by 5% QoQ
The revenue has dropped by 100% year-on-year
The gross profit has dropped by 100% year-on-year
Sector: Healthcare
Industry: Medical Devices
Peers: NWBO

Key stats

What are the main financial stats of BJDX
Market
Shares outstanding
2.69M
Market cap
$1.48M
Enterprise value
-$376,893
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.24
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$9.95M
EBITDA
-$9.17M
Free cash flow
-$9.02M
Per share
EPS
-$9.08
Free cash flow per share
-$8.22
Book value per share
$2.34
Revenue per share
$0
TBVPS
$4.44
Balance sheet
Total assets
$4.87M
Total liabilities
$1.97M
Debt
$352,977
Equity
$2.89M
Working capital
$1.45M
Liquidity
Debt to equity
0.12
Current ratio
1.82
Quick ratio
1.25
Net debt/EBITDA
0.2
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-122.6%
Return on equity
-168.4%
Return on invested capital
-559.7%
Return on capital employed
-321.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BJDX stock price

How has the Bluejay Diagnostics stock price performed over time
Intraday
1.85%
1 week
-16.67%
1 month
-23.56%
1 year
-91.36%
YTD
-54.92%
QTD
-31.49%

Financial performance

How have Bluejay Diagnostics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.31M
Net income
-$9.95M
Gross margin
N/A
Net margin
N/A
The revenue has dropped by 100% year-on-year
The gross profit has dropped by 100% year-on-year
BJDX's operating income is down by 11% year-on-year
BJDX's net income is down by 7% year-on-year

Growth

What is Bluejay Diagnostics's growth rate over time

Valuation

What is Bluejay Diagnostics stock price valuation
P/E
N/A
P/B
0.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
BJDX's EPS is up by 5% QoQ
BJDX's equity has dropped by 75% year-on-year and by 44% since the previous quarter
BJDX's P/B is 70% below its last 4 quarters average of 0.8
The revenue has dropped by 100% year-on-year

Efficiency

How efficient is Bluejay Diagnostics business performance
Bluejay Diagnostics's return on equity has shrunk by 174% YoY and by 35% QoQ
The ROA has plunged by 122% YoY and by 26% from the previous quarter
Bluejay Diagnostics's return on invested capital has decreased by 15% YoY and by 13% QoQ

Dividends

What is BJDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BJDX.

Financial health

How did Bluejay Diagnostics financials performed over time
The total assets is 147% higher than the total liabilities
BJDX's quick ratio has plunged by 80% YoY and by 31% from the previous quarter
Bluejay Diagnostics's current ratio has plunged by 75% YoY and by 22% from the previous quarter
Bluejay Diagnostics's debt is 88% less than its equity
The company's debt to equity has surged by 200% YoY and by 71% QoQ
BJDX's equity has dropped by 75% year-on-year and by 44% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.